Duopharma Biotech Berhad (7148.KL)
MYR 1.24
(-0.8%)
MYR 1.24
(-0.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 704.72 Million | 696.71 Million | 639.17 Million | 569.9 Million | 576.46 Million | 498.72 Million |
| Cost of Revenue | 436.4 Million | 416.89 Million | 385.19 Million | 336.7 Million | 344.39 Million | 294.24 Million |
| Gross Profit | 268.32 Million | 279.81 Million | 253.98 Million | 233.2 Million | 232.06 Million | 204.48 Million |
| Operating Expenses | 187.45 Million | 187.39 Million | 165.12 Million | 151.34 Million | 155.35 Million | 140.27 Million |
| Selling, General and Administrative Expenses | 187.45 Million | 186.58 Million | 165.78 Million | 150.81 Million | 155.35 Million | 137.82 Million |
| Research and Development Expenses | - | - | - | - | - | 11.48 Million |
| Other Expenses | - | 813 Thousand | -661 Thousand | 531 Thousand | 518 Thousand | 1.08 Million |
| Cost and Expenses | 623.85 Million | 604.29 Million | 550.31 Million | 488.04 Million | 499.74 Million | 434.52 Million |
| Operating Income | 80.87 Million | 92.91 Million | 88.75 Million | 81.85 Million | 77.64 Million | 65.28 Million |
| Interest Expense | 18.19 Million | 9.09 Million | 6.43 Million | 6.52 Million | 7.96 Million | 7.55 Million |
| Income Tax Expense | 10.62 Million | 14.73 Million | 17.3 Million | 17.54 Million | 15.53 Million | 12.02 Million |
| Earnings before Tax | 63.26 Million | 84.85 Million | 82.98 Million | 76.15 Million | 70.8 Million | 59.66 Million |
| Net Income | 52.64 Million | 70.11 Million | 65.68 Million | 58.61 Million | 55.27 Million | 47.64 Million |
| Earnings Per Share Basic | 0.05 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 |
| Earnings Per Share Diluted | 0.05 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 |
| Weighted Average Shares Outstanding | 958.51 Million | 948.3 Million | 928.34 Million | 923.62 Million | 893.62 Million | 874.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 958.51 Million | 948.3 Million | 928.34 Million | 923.62 Million | 893.62 Million | 874.56 Million |
| Gross Margin | 0.38 | 0.40 | 0.40 | 0.41 | 0.40 | 0.41 |
| EBIT Margin | 0.18 | 0.19 | 0.19 | 0.20 | 0.18 | 0.18 |
| Profit Margin | 0.07 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| EBITDA | 124.51 Million | 130.62 Million | 121.91 Million | 112.43 Million | 105.96 Million | 92.12 Million |
| Earnings Before Tax Margin | 0.11 | 0.13 | 0.14 | 0.14 | 0.13 | 0.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 218.32 Million | 192.96 Million | 167.5 Million | 704.72 Million | 169.23 Million | 167.51 Million |
| Cost of Revenue | 143.38 Million | 118.69 Million | 112.05 Million | 436.4 Million | 104.76 Million | 101.64 Million |
| Gross Profit | 74.93 Million | 74.27 Million | 55.44 Million | 268.32 Million | 64.47 Million | 65.87 Million |
| Operating Expenses | 47.6 Million | 47.81 Million | 45.26 Million | 187.45 Million | 47.78 Million | 45.24 Million |
| Selling, General and Administrative Expenses | 47.6 Million | 47.81 Million | 45.26 Million | - | 45.26 Million | 44.49 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 16 Thousand | - | - | - | - | - |
| Cost and Expenses | 190.99 Million | 166.51 Million | 157.32 Million | 623.85 Million | 152.54 Million | 146.88 Million |
| Operating Income | 27.33 Million | 26.45 Million | 10.18 Million | 80.87 Million | 16.69 Million | 20.63 Million |
| Interest Expense | 6.83 Million | 6.95 Million | 4.89 Million | 17.68 Million | 5.65 Million | 4.6 Million |
| Income Tax Expense | 5.27 Million | 4.82 Million | -1.46 Million | 10.62 Million | 2.45 Million | 3.97 Million |
| Earnings before Tax | 21.96 Million | 20.1 Million | 7.03 Million | 63.26 Million | 11.42 Million | 16.51 Million |
| Net Income | 16.68 Million | 15.27 Million | 8.5 Million | 52.64 Million | 8.97 Million | 12.54 Million |
| Earnings Per Share Basic | 0.02 | 0.02 | 0.01 | - | 0.01 | 0.01 |
| Earnings Per Share Diluted | 0.02 | 0.02 | 0.01 | - | 0.01 | 0.01 |
| Weighted Average Shares Outstanding | 961.94 Million | 961.94 Million | 961.94 Million | 958.51 Million | 961.94 Million | 957.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 961.94 Million | 961.94 Million | 961.94 Million | 958.51 Million | 961.94 Million | 957.78 Million |
| Gross Margin | 0.34 | 0.38 | 0.33 | 0.38 | 0.38 | 0.39 |
| EBIT Margin | 0.18 | 0.20 | 0.15 | - | 0.16 | 0.18 |
| Profit Margin | 0.08 | 0.08 | 0.05 | 0.07 | 0.05 | 0.07 |
| EBITDA | 38.67 Million | 37.77 Million | 24.38 Million | - | 27.36 Million | 30.43 Million |
| Earnings Before Tax Margin | 0.13 | 0.14 | 0.06 | 0.11 | 0.10 | 0.12 |
UNIVASTU
EPM
DIXON
TANAA
DEI
FIRST-B